Vaginal trichomoniasis: Clinical sciences

1,658views

Vaginal trichomoniasis: Clinical sciences

Reproductive and Breast

Reproductive and Breast

Approach to breast pain (mastalgia): Clinical sciences
Approach to nipple discharge: Clinical sciences
Breast abscess: Clinical sciences
Mastitis: Clinical sciences
Approach to a breast mass and asymmetry: Clinical sciences
Breast cancer screening: Clinical sciences
Breast cyst: Clinical sciences
Breast papilloma: Clinical sciences
Ductal carcinoma in situ: Clinical sciences
Fibroadenoma: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Inflammatory breast cancer: Clinical sciences
Invasive ductal carcinoma: Clinical sciences
Invasive lobular carcinoma: Clinical sciences
Lobular carcinoma in situ: Clinical sciences
Emergency contraception: Clinical sciences
Infertility: Clinical sciences
Permanent contraception (sterilization): Clinical sciences
Reversible contraception: Clinical sciences
Approach to vaginal discharge: Clinical sciences
Approach to vulvar skin disorders: Clinical sciences
Bacterial vaginosis: Clinical sciences
Chlamydia trachomatis infection: Clinical sciences
Neisseria gonorrhoeae infection: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Sexually transmitted infection screening (Family medicine): Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Uterine leiomyoma: Clinical sciences
Vaginal trichomoniasis: Clinical sciences
Vulvar skin disorders (benign): Clinical sciences
Vulvovaginal candidiasis: Clinical sciences
Approach to postmenopausal bleeding: Clinical sciences
Perimenopause, menopause, and primary ovarian insufficiency: Clinical sciences
Adenomyosis: Clinical sciences
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Approach to chronic pelvic pain (GYN): Clinical sciences
Approach to dysmenorrhea: Clinical sciences
Approach to primary amenorrhea: Clinical sciences
Approach to secondary amenorrhea: Clinical sciences
Endometriosis: Clinical sciences
Polycystic ovary syndrome (PCOS): Clinical sciences
Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD): Clinical sciences
Primary dysmenorrhea: Clinical sciences
Approach to adnexal masses: Clinical sciences
Cervical cancer screening: Clinical sciences
Cervical dysplasia and cervical cancer: Clinical sciences
Endometrial intraepithelial neoplasia (hyperplasia) and carcinoma: Clinical sciences
Gestational trophoblastic disease (GTD) and neoplasia (GTN): Clinical sciences
Ovarian cancer: Clinical sciences
Vulvar dysplasia and vulvar cancer: Clinical sciences
Adnexal torsion: Clinical sciences
Benign prostatic hypertrophy and prostate cancer: Clinical sciences
Testicular torsion (pediatrics): Clinical sciences
Testicular cancer: Clinical sciences
Anatomy clinical correlates: Breast
Anatomy clinical correlates: Female pelvis and perineum
Anatomy clinical correlates: Inguinal region
Anatomy clinical correlates: Male pelvis and perineum
Chlamydia trachomatis
Gardnerella vaginalis (Bacterial vaginosis)
Haemophilus ducreyi (Chancroid)
Neisseria gonorrhoeae
Staphylococcus aureus
Treponema pallidum (Syphilis)
Candida
Trichomonas vaginalis
Herpes simplex virus
Human papillomavirus
Benign breast conditions: Pathology review
Breast cancer: Pathology review
Amenorrhea: Pathology review
Cervical cancer: Pathology review
Ovarian cysts and tumors: Pathology review
Sexually transmitted infections: Vaginitis and cervicitis: Pathology review
Uterine disorders: Pathology review
Vaginal and vulvar disorders: Pathology review
Disorders of sex chromosomes: Pathology review
Disorders of sexual development and sex hormones: Pathology review
Sexually transmitted infections: Warts and ulcers: Pathology review
Penile conditions: Pathology review
Prostate disorders and cancer: Pathology review
Testicular and scrotal conditions: Pathology review
Testicular tumors: Pathology review
Androgens and antiandrogens
Aromatase inhibitors
Estrogens and antiestrogens
Progestins and antiprogestins
Uterine stimulants and relaxants
Adrenergic antagonists: Alpha blockers
PDE5 inhibitors

Decision-Making Tree

Transcript

Watch video only

Vaginal trichomoniasis is among the most prevalent sexually transmitted infections, or STIs, worldwide. It is caused by the protozoan parasite, Trichomonas vaginalis. Most patients infected with trichomonas have minimal or no symptoms, and untreated infections can last for months to years. Trichomonas infection is associated with an increased risk of both HIV acquisition and HIV shedding, and it increases the risk of pelvic inflammatory disease among HIV-positive patients. Additionally, it has been associated with an increased risk of cervical cancer. In pregnancy, trichomonas infection increases the risk of preterm birth, prelabor rupture of membranes and small for gestational age infants.

Your first step in evaluating a patient who presents with a chief concern suggesting vaginal trichomoniasis is obtaining a focused history and physical exam. This should include a sexual history, such as recent sexual activity or new partners, so be sure to have a private and confidential discussion. Although it might be difficult, you should ask caregivers of young patients to step out of the room for this discussion. Additionally, always consider sexual assault or abuse whenever a young patient has a positive sexual activity history, especially if the patient is a child. If there is abuse going on, you will need to follow up with allegations of abuse in accordance with your State’s law.

Now, keep in mind that trichomoniasis can be spread through vaginal fluids So some practices like sharing of sex toys can cause infection. In addition to sexual history, ask about hygiene practices, such as douching, which can remove some of the bacteria that make up the normal vaginal flora, increasing the risk of overgrowth of infectious pathogens. Although most patients are usually asymptomatic, some may report a malodorous vaginal discharge, vulvar pruritus or irritation, and dysuria.

Physical exam findings include a yellow frothy vaginal discharge; as well as vaginal or cervical erythema with petechiae, which is often referred to as a “strawberry cervix.” Based on these findings, you should suspect vaginal trichomoniasis.

Here is a high-yield fact! In the United States, the prevalence of vaginal trichomoniasis is almost 10 times higher among black patients than non-Hispanic white patients. Some additional risk factors for trichomonas infection include socioeconomic factors like incarceration, having less than a high school education, and poverty.

So, if you suspect vaginal trichomoniasis, let’s take a look at your next step to confirm the diagnosis. To do this, obtain samples of the vaginal discharge from the vaginal walls and fornices. Evaluate the discharge with saline microscopy, particularly looking for motile trichomonads, and assess the vaginal pH. In addition, you may perform nucleic acid amplification testing, or NAAT, for Trichomonas vaginalis. While NAAT testing is highly sensitive and detects more trichomonas infections, keep in mind that it’s more expensive and less timely than microscopy.

Okay, time for a couple of clinical pearls! First, vaginal cultures can be used to detect Trichomonas vaginalis, but these are rarely used, as NAAT testing has higher sensitivity and better detection rates. Additionally, there are also some FDA-approved rapid tests available for detecting Trichomonas vaginalis. Second, vaginal trichomoniasis has a high prevalence in patients with HIV infection, can increase viral shedding, and is strongly associated with pelvic inflammatory disease among these patients. For these reasons, yearly screening for trichomonas is recommended for patients with HIV infection.

Now let’s review our results. If there is an absence of trichomonads on saline microscopy, the vaginal pH is lower than or equal to 4.5, or a NAAT is negative for Trichomonas, consider an alternative diagnosis. However, keep in mind that time matters here, and sensitivity decreases quickly within 1 hour after specimen collection, so you should attempt to evaluate it immediately!

Sources

  1. "ACOG practice bulletin no. 215: Vaginitis in nonpregnant patients" Obstet Gynecol (2020)
  2. "Sexually transmitted infections treatment guidelines, 2021" MMWR Recomm Rep (2021)